These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 14987919

  • 1. The hepoxilin stable analogue, PBT-3, inhibits primary, platelet-related hemostasis in whole blood measured in vitro with the PFA-100.
    Reynaud D, Clark D, Qiao N, Rand ML, Pace-Asciak CR.
    Thromb Res; 2003; 112(4):245-8. PubMed ID: 14987919
    [No Abstract] [Full Text] [Related]

  • 2. The hepoxilin analog PBT-3 inhibits heparin-activated platelet aggregation evoked by ADP.
    Reynaud D, Hinek A, Pace-Asciak CR.
    FEBS Lett; 2002 Mar 27; 515(1-3):58-60. PubMed ID: 11943194
    [Abstract] [Full Text] [Related]

  • 3. Endogenous hepoxilin A3, produced under short duration of high shear-stress, inhibits thrombin-induced aggregation in human platelets.
    Margalit A, Granot Y.
    Biochim Biophys Acta; 1994 Feb 23; 1190(1):173-6. PubMed ID: 8110811
    [Abstract] [Full Text] [Related]

  • 4. Dihomo-gamma-linolenate suppresses platelet aggregation when administered in vitro or in vivo.
    Willis AL, Comai K, Kuhn DC, Paulsrud J.
    Prostaglandins; 1974 Dec 25; 8(6):509-19. PubMed ID: 4462154
    [No Abstract] [Full Text] [Related]

  • 5. In vitro methods and the study of platelet mechanisms.
    Packham MA, Mustard JF.
    Vox Sang; 1981 Dec 25; 40 Suppl 1():22-35. PubMed ID: 6794224
    [No Abstract] [Full Text] [Related]

  • 6. The influence of the haematocrit on primary haemostasis in vitro.
    Eugster M, Reinhart WH.
    Thromb Haemost; 2005 Dec 25; 94(6):1213-8. PubMed ID: 16411396
    [Abstract] [Full Text] [Related]

  • 7. Heparin and platelet function.
    Zucker MB.
    Fed Proc; 1977 Jan 25; 36(1):47-9. PubMed ID: 318624
    [No Abstract] [Full Text] [Related]

  • 8. Platelets and atherosclerosis.
    Jørgensen KA, Dyerberg J.
    Adv Nutr Res; 1983 Jan 25; 5():57-75. PubMed ID: 6303066
    [No Abstract] [Full Text] [Related]

  • 9. Effects on primary haemostasis of an anti-inflammatory agent with 5-lipoxygenase and cyclooxygenase inhibitory activity.
    Hernandez MR, Tonda R, Pedreño J, Salas E, Arderiu G, Pino M, Serradell M, Escolar G.
    J Cardiovasc Med (Hagerstown); 2006 Dec 25; 7(12):859-65. PubMed ID: 17122671
    [Abstract] [Full Text] [Related]

  • 10. CLOCK regulates circadian platelet activity.
    Ohkura N, Oishi K, Sudo T, Hayashi H, Shikata K, Ishida N, Matsuda J, Horie S.
    Thromb Res; 2009 Dec 25; 123(3):523-7. PubMed ID: 18433843
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US.
    Circulation; 2007 Jun 26; 115(25):3156-64. PubMed ID: 17562955
    [Abstract] [Full Text] [Related]

  • 12. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ, Bös M, Weber D, Winkler K, Hanfland P, Preusse CJ.
    Semin Thromb Hemost; 2005 Jun 26; 31(4):426-40. PubMed ID: 16149021
    [Abstract] [Full Text] [Related]

  • 13. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy.
    Christie DJ, Kottke-Marchant K, Gorman RT.
    Platelets; 2008 Mar 26; 19(2):104-10. PubMed ID: 17852773
    [Abstract] [Full Text] [Related]

  • 14. Somatostatin: influence on hemostasis--a review.
    Mielke CH, Rodvien R.
    Metabolism; 1978 Sep 26; 27(9 Suppl 1):1369-75. PubMed ID: 683004
    [No Abstract] [Full Text] [Related]

  • 15. Alteration of release and role of adenosine diphosphate and thromboxane A2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome.
    Honda N, Ohnishi K, Fujishiro T, Ikeda M, Ito K.
    Am J Vet Res; 2007 Dec 26; 68(12):1399-406. PubMed ID: 18052747
    [Abstract] [Full Text] [Related]

  • 16. Effect of titanium maxillofacial implants and osteosynthesis materials on platelet function.
    Stathopoulos P, Theodossiades G, Mourouzis C, Evangelou A.
    Br J Oral Maxillofac Surg; 2011 Oct 26; 49(7):538-41. PubMed ID: 20934238
    [Abstract] [Full Text] [Related]

  • 17. Monitoring anticoagulation of primary haemostasis--estimation of platelet function in whole blood assays.
    Calatzis A, Leitner M, Panzer S.
    Hamostaseologie; 2009 Aug 26; 29(3):279-84. PubMed ID: 19644601
    [Abstract] [Full Text] [Related]

  • 18. The effect of some epsilon-aminocaproic acid derivatives on platelet responses.
    Bruzgo I, Tomasiak M, Stelmach H, Midura-Nowaczek K.
    Acta Biochim Pol; 2004 Aug 26; 51(1):73-80. PubMed ID: 15094827
    [Abstract] [Full Text] [Related]

  • 19. [Thrombocyte functions in malignant blood diseases].
    Lisichkov T, Avramova D, Dobreva A, Meshkov T, Ignatova E.
    Vutr Boles; 1987 Aug 26; 26(4):74-7. PubMed ID: 3478895
    [Abstract] [Full Text] [Related]

  • 20. Platelet function as an indicator of adequate dialysis.
    Rabiner SF, Drake RF.
    Kidney Int Suppl; 1975 Jan 26; (2):144-6. PubMed ID: 1057672
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.